Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$73.01 USD
+0.60 (0.83%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $73.03 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 261 - 280 ( 519 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
If Big Pharma Spent $10B+ on CAR-Ts, How Much for NASH? - Part 1
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y